(Q43900414)

27 November 2017

title

Premature coronary heart disease in SLE: can we prevent progression? (English)

1 reference

27 November 2017

main subject

coronary artery disease

1 reference

8

A Doria

1 reference

27 November 2017

L Iaccarino

1

1 reference

27 November 2017

S Bettio

2

1 reference

27 November 2017

M Zen

3

1 reference

27 November 2017

L Nalotto

4

1 reference

27 November 2017

M Gatto

5

1 reference

27 November 2017

R Ramonda

6

1 reference

27 November 2017

L Punzi

7

1 reference

27 November 2017

publication date

1 October 2013

1 reference

27 November 2017

1 reference

27 November 2017

volume

22

1 reference

27 November 2017

issue

12

1 reference

27 November 2017

page(s)

1232-1242

1 reference

Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Systemic lupus erythematosus one disease or many?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Preventive strategies in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

SLE diagnosis and treatment: when early is early

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

The bimodal mortality pattern of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for V

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Noncalcified coronary plaque in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Semiquantified noncalcified coronary plaque in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Inflammation and accelerated atherosclerosis: basic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Atherosclerosis in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Accelerated atherosclerosis in autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Innate and adaptive immunity in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Human FoxP3+ regulatory T cells in systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Physical activity in patients with systemic lupus erythematosus and matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Clinical practice. Aspirin for primary prevention of coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

The role of antiplatelets in hypertension and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Changes of CD4+CD25+ regulatory T cells in patients with acute coronary syndrome and the effects of atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Use of atorvastatin in systemic lupus erythematosus in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Preventing microalbuminuria in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Antiproteinuric effect of angiotensin-converting enzyme inhibitors and an angiotensin II receptor blocker in patients with lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Vitamin D endocrine system involvement in autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Vitamin D and cardiovascular prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Effect of vitamin D on blood pressure: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Calcium/vitamin D supplementation and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Vitamin D insufficiency in a large female SLE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

The kaleidoscope of glucorticoid effects on immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Effect of mycophenolate mofetil on atherosclerosis in a rabbit model: initial histologic and immunohistochemical analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Cardiac allograft vasculopathy in heart transplant patients: pathologic and clinical aspects for angioplasty/stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Vascular remodeling 1 year after cardiac transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Advancing immunosuppression therapy to counter the progression of cardiac allograft vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Natural regulatory T cells control the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

Implications of immunosuppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313492871

21 January 2018

Identifiers

DOI

10.1177/0961203313492871

1 reference

27 November 2017

1 reference